RxDoctor Payments DataLook up a doctor →

Khanjan Nagarsheth, MD

Vascular Surgery · Baltimore, MDNPI 1275789430

Payments from drug & device makers

$394,982in general payments, 2019–2025

Across 459 payments — averaging $860.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$209K
  • Boston Scientific$107K
  • Stryker$56K
  • Inari Medical, Inc.$5K
  • Medtronic$3K
  • Endologix LLC$2K
  • plus $13K from 33 others

What the payments were for

  • Speaking & faculty fees$1,2004%
  • Grants$2,5008%
  • Travel & lodging$10,99233%
  • Food & beverage$18,34555%
  • Entertainment$430%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$394,982 in reported general payments places this provider in the 95th percentile of 104 vascular surgery providers in Maryland.

See all vascular surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$598,780
Medicare patients
537
Services billed
1,483

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate38$268

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →